Working Student Investment & Dealflow (m/f/d) 20h/week
Apollo Health Ventures is a venture capital firm investing in early-stage innovative biotech companies developing transformative therapeutics with a particular focus on aging biology and healthy lifespan. Our portfolio includes companies such as Aeovian Pharmaceuticals Haya Therapeutics and Therini Bio and we have co-founded companies including Refoxy Pharma and Booster Therapeutics.
We are seeking a Working Student (m/f/d) to join our international investment team and support deal sourcing scientific evaluation and internal investment processes. The role is remote within Germany with optional presence in our Berlin office.
What Youll Do
Manage and maintain our internal dealflow platform ensuring accurate tracking of opportunities
Screen assess and discuss incoming investment opportunities with the investment team
Document evaluations and key insights within the dealflow system
Conduct scientific and competitive research to support due diligence and investment thesis development
Interact with biotech founders academic groups and industry partners within our network
Contribute to strategic and analytical projects across the investment team
What Were Looking For
Masters student in biomolecular sciences biomedicine pharmaceutical sciences cancer biology neuroscience or a related life science discipline
Strong interest in drug development translational science and biotech innovation
Fluent in English (German not required)
Enrolled at a German university and residing in Germany
Highly analytical structured proactive and comfortable working in a fast-paced environment
Why Join Us
Direct exposure to early-stage biotech investing and venture creation
Hands-on involvement in evaluating cutting-edge therapeutic programs
Flexible remote work within Germany (Berlin office optional) 20h/week
Opportunity to work closely with experienced investors and entrepreneurs shaping the future of healthcare
Your application has been successfully submitted!
Apollo Health Ventures is a transatlantic early stage Venture Capital firm actively co-founding and investing in age-related healthcare companies.